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Diabetic peripheral neuropathic pain (DPNP) is the most devastating complication of
diabetes mellitus. Unfortunately, successful therapy for DPNP remains a challenge
because its pathogenesis is still elusive. However, DPNP is believed to be due partly
to abnormal hyperexcitability of dorsal root ganglion (DRG) neurons, but the relative
contributions of specific functional subtypes remain largely unknown. Here, using the
strepotozotocin (STZ) rat model of DPNP induced by a STZ injection (60 mg/kg, i.p),
and intracellular recordings of action potentials (APs) from DRG neurons in anesthetized
rats, we examined electrophysiological changes in C-and Aβ-nociceptive and Aβ-low
threshold mechanoreceptive (LTM) neurons that may contribute to DPNP. Compared
with control, we found in STZ-rats with established pain hypersensitivity (5 weeks
post-STZ) several significant changes including: (a) A 23% increase in the incidence
of spontaneous activity (SA) in Aβ-LTMs (but not C-mechanosensitive nociceptors)
that may cause dysesthesias/paresthesia suffered by DPNP patients, (b) membrane
hyperpolarization and a∼85% reduction in SA rate in Aβ-LTMs by Kv7 channel activation
with retigabine (6 mg/kg, i.v.) suggesting that Kv7/M channels may be involved in
mechanisms of SA generation in Aβ-LTMs, (c) decreases in AP duration and in duration
and amplitude of afterhyperpolarization (AHP) in C-and/or Aβ-nociceptors. These faster
AP and AHP kinetics may lead to repetitive firing and an increase in afferent input to the
CNS and thereby contribute to DPNP development, and (d) a decrease in the electrical
thresholds of Aβ-nociceptors that may contribute to their sensitization, and thus to the
resulting hypersensitivity associated with DPNP.
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INTRODUCTION
Diabetic peripheral neuropathic pain (DPNP) is the most
debilitating complication of diabetes mellitus with up to
50% of people with diabetic neuropathy (DN) having some
degree of PNP (e.g., Lee-Kubli and Calcutt, 2014). Patients
with DPNP usually experience a range of unpleasant positive
symptoms such as spontaneous/ongoing pain, mechanical
and cold hypersensitivity and dysesthesias/paresthesias, as
well as negative symptoms notably heat hypoalgesia (e.g.,
Schreiber et al., 2015). Successful therapy for DPNP remains
a challenge because currently available drugs have either
limited efficacy and/or adverse side effects. Despite its high
prevalence and clinical importance, the pathophysiology of
DPNP is still illusive. However, several mechanisms have
been implicated in its pathogenesis including mechanisms
that involve structural changes in the peripheral nervous
system (Polydefkis et al., 2004; Shun et al., 2004), and
functional changes such as abnormal hyperexcitability of
dorsal root ganglion (DRG) and CNS neurons (see (Baron
et al., 2010)). Like other models of PNP, the hypersensitivity
and/or ongoing pain associated with DPNP are likely to
result from changes in excitability of the primary afferent
neurons (Burchiel et al., 1985; Hong et al., 2004; Jagodic
et al., 2007; Serra et al., 2012). Several animal studies using
rodent models of DPNP have shown that both C- and
A-fiber DRG neurons exhibit aberrant spontaneous activity
(SA), the key characteristic of neuronal hyperexcitability
(Burchiel et al., 1985; Ahlgren et al., 1992; Chen and Levine,
2001; Khan et al., 2002). While these studies suggest that
both A-and C-fiber afferent fibers are involved in DPNP
pathogenesis, the relative contributions of specific functional
afferent subtypes that are likely to mediate different aspects
of DPNP remain unknown. Indeed, little is known about
the sensory receptive properties (sensory modality) of the
afferent neurons involved in development and/or maintenance
DPNP pathogenesis.
The primary aim of this in vivo study was to examine in
the streptozotocin (STZ) rat model of DPNP electrophysiological
changes in physiologically identified C- and A-fiber DRG neurons
that might contribute to their hyperexcitability, and thereby
to DPNP development. We found (5 weeks post-STZ) several
significant changes in both nociceptive and non-nociceptive
DRG neurons in STZ rats. These include SA in A/β-LTMs
(but not in C-mechanosensitive nociceptors) that may cause
dysesthesias/paresthesias experienced by many patients with
DPNP. Interestingly, we also found that activation of Kv7
channels with retigabine caused membrane hyperpolarization
and marked suppression of the SA in Aα/β-LTMs suggesting
that these channels may be involved in mechanisms of SA
generation in this subtype of Aβ-LTMs. It should be note that
a decrease in expression or a change in activation properties
of Kv7 channels that underlie the M current that normally acts
as a “dynamic brake” on repetitive action potential discharges
(see Brown and Passmore, 2009) could result in membrane
depolarization, and render neurons more prone to action
potential firing.
METHODS
The Animal Model of DPNP and in vivo
Preparation
Male Sprague–Dawley rats (250–300 g) were used in the present
study. They were housed in groups of 4 per cage, in a room
(with room temperature maintained between 21 and 24◦C)
in the animal house of Liverpool University (UK), under
standard laboratory conditions with 12-h light\dark cycles. The
experimental protocols were approved by the University of
Liverpool Ethical review committee, and complied throughout
with the UK Animals (Scientific Procedures) Act 1986. The
terminal surgery and recordings were conducted under deep
anesthesia (sodium pentobarbitone 60 mg/kg i.p.). At the end
of experiments, animals were humanely killed with an overdose
of sodium pentobarbitone. We used the STZ rat model of
DPNP that involves a single injection of STZ (60 mg/kg,
i.p.) after an overnight fast to reduce competition between
glucose and STZ for uptake into pancreatic β-cells as reported
previously (see Djouhri et al., 2019). It is noteworthy that
hypoinsulinemia and hyperglycemia caused by STZ is due to
its cytotoxicity to pancreatic β cells. The STZ model (model
of type 1 diabetes) is more commonly used than other
models of DPNP because of its low cost, rapid induction,
greater stability and relative lack of toxicity to other organs
(Skovso, 2014). More imoprtantly, the STZ model is known
to exhibit long lasting behavioral signs of DPNP including
mechanical and heat hypersensitivity (see Djouhri et al., 2019 and
section “Discussion”).
Pain Behavioral Testing
Pain behavioral testing was conducted on 10 STZ rats by an
experimenter blind to the various treatment animal groups as
reported recently (Djouhri et al., 2019). Briefly, paw withdrawal
threshold (PWT), paw withdrawal latency (PWL), and cold
escape/nocifensive behavior, were assessed on the left hind paw
of each STZ rat. Mechanical hypersensitivity was indicated
by a significant decrease in the mean PWT, whereas heat
hypersensitivity was indicated by a significant decrease in
the mean PWL to a noxious heat. Cold hypersensitivity was
assessed using a hot/cold plate analgesiometer (Ugo Basile,
Milan, Italy) and a stop watch to record the duration (in
seconds) of the escape/nocifensive behavior (licking, lifting,
guarding, shaking or biting of the hind paw, or jumping)
in a 2 min period in rats before and after STZ treatment.
Cold hypersensitivity was indicated by a significant decrease in
the duration of cold-evoked responses as reported previously
(e.g., Orio et al., 2009). STZ rats were also assessed for
the presence of spontaneous foot lifting (SFL), a behavioral
sign of spontaneous/ongoing pain as described previously
(Djouhri et al., 2019).
In vivo Electrophysiological Recordings
Intracellular recordings were made in deeply anesthetized STZ
rats (n = 28) 5 weeks post-STZ or in control (vehicle treated)
rats (n = 18 rats) of similar age/weight. General anesthesia
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was induced by sodium pentobarbitone (60 mg/kg. i.p.). The
relatively large number of rats used is due to the low percentage
(about 23%) of neurons with SA (see section “Results”).
This means finding a spontaneously firing neuron requires
4 or more successful experiments with at least 4 neurons
in each experiment. Full details of the animal preparation
were as reported previously (Djouhri et al., 2018). Briefly, to
allow artificial ventilation and monitoring of end-tidal CO2, a
tracheotomy was performed. CO2 was maintained between 3
and 4% by adjusting the volume and rate of the respiratory
pump. The left jugular vein and carotid artery were tabulated
to enable, respectively, regular injections of additional doses of
anesthetic (sodium pentobaribtone 10mg/kg) and monitoring
of blood pressure (normally ∼80–100 mmHg). A laminectomy
was performed from vertebrae L2-L6 as reported previously
(Djouhri et al., 2018). Intracellular voltage recordings from
somata of L4 or L5 DRG neurons were obtained using sharp
glass microelectrodes filled with 3M or 1M KCl. Somatic action
potentials (APs) were antidromically evoked by dorsal root
stimulation with single rectangular pulses (0.03 ms duration for
A-fiber neurons or 0.3 ms for C-fiber neurons). The electrical
threshold (the minimum stimulus (in volts) applied to the dorsal
root that evoked a somatic AP) was measured. The stimulus
intensity (up to 25 V) was adjusted to twice threshold for
A-fiber neurons and between 1 and 1.5 times threshold for
C-fiber neurons. As reported previously (Djouhri et al., 2006),
spontaneous firing/activity (SA) which is the ongoing firing
in the absence of any known stimulus, was recoded (when
present) before modality testing to avoid the search stimuli
influencing such firing. In all neurons, the assessment period
for SA was initially 2 min. The recording time was extended
up to 5 min for neurons exhibiting SA during this initial
observation period to calculate the rate of SA. SA rate was
calculated by counting the number of action potentials during the
recording period.
Conduction Velocity, Action Potential
Recordings, and Selection Criteria
The conduction velocity (CV, m/s) of each neuron was calculated
by dividing the conduction distance between the recording and
stimulating sites by the latency to onset of the evoked AP.
Neurons were classified according to their dorsal root CVs
as C (≤ 0.8m/s), Aδ (1.5–6.5 m/s) or Aα/β (>6.5 m/s) (see
Fang et al., 2002). These borderlines were relatively low, for
reasons discussed previously including inclusion of utilization
time (Djouhri and Lawson, 2001). As reported previously (e.g.,
Fang et al., 2002; Djouhri et al., 2018), APs were recorded online
with a CED (Cambridge Electronics Design) 1401 plus interface
and the spike II programs from CED and were subsequently
analyzed offline using CED Spike II program. For each neuron,
various variables were measured as described previously (see
(Djouhri et al., 2012)). These include CV, resting membrane
potential (Em), durations of AP at base, rise time (RT) and fall
time (FT) as well as AP height and AP overshoot. AHP duration
to 80% recovery (AHP80%) and AHP amplitude (between Em
and maximum AHP depth). were also measured. Neurons were
included in the analysis only if their Ems were equal to, or more
negative, than−40 mV, and an AHP.
Sensory Receptive Properties
The sensory receptive properties of DRG neurons were identified
using natural innocuous and noxious mechanical and thermal
stimuli as described previously (Fang et al., 2005; Djouhri et al.,
2018). Briefly, non-nociceptive neurons including low threshold
mechanorecptive (LTMs) were those units that responded to
non-noxious mechanical stimuli including light brushing of limb
fur with a fine paint-brush, skin contact and light pressure with
blunt objects. Only cutaneous Aβ-LTMs were included in the
current study; they were classed as slowly adapting units or
rapidly adapting units (see Fang et al., 2005; Djouhri et al., 2018).
Slowly conducting C-, Aδ-fiber LTMs were not encountered in
the present study. Nociceptive neurons were those that failed to
respond to the non-noxious mechanical stimuli but responded
either to noxious mechanical stimuli (applied with a needle,
fine forceps or coarse toothed forceps) only, or to both noxious
mechanical and noxious heat stimuli (hot water at 50–65◦C
applied with a syringe). These are referred to as C-mechano-
sensitive nociceptors. C-mechano-insensitive nociceptors were
not included in the present study.
Statistical Tests
The behavioral data are normally distributed (Shapiro–Wilk
normality test) and are therefore presented as the mean ± SEM.
Comparisons between values before and after STZ treatment
were made with paired t-tests (Figure 1). Comparisons of
percentage change were made using the Fisher exact test
(Figure 2). Most of the electrophysiological data (not normally
distributed) are presented as medians and compared with the
nonparametric Mann–Whitney U test (Figures 3, 4). All tests
were made using GraphPad Prism software, version 8 (GraphPad,
San Diego, CA, United States), and were two-tailed. Values of
P < 0.05 were considered significant. Statistical significance:
∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001.
RESULTS
STZ Rats Exhibit Behavioral Sings of
Mechanical and Heat, but Not Cold,
Hypersensitivity or Spontaneous Pain
We have previously shown that STZ-diabetic rats exhibit
behavioral signs of mechanical and heat hypersensitivity, but
not cold hypersensitivity or spontaneous/ongoing pain (Djouhri
et al., 2019). To confirm that the STZ-rats on which the
present electrophysiological experiments were conducted also
show behavioral indices of DPNP, we assessed pain behaviors
in 10 rats including 7 STZ-rats from which the spontaneously
firing Aβ-LTMs were recorded (see below). Consistent with
our previous study (Djouhri et al., 2019), we found 5 weeks
post-STZ that all STZ-rats exhibited: (1) significant decreases
in the mean PWT and PWL (P < 0.01) indicating that
they developed behavioral signs of mechanical and heat
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hypersensitivity respectively (Figure 1), and (2) no behavioral
signs of cold hypersensitivity or spontaneous/ongoing pain
(data not shown).
In vivo Intracellular Voltage Recordings
in Control and STZ Rats
In vivo intracellular voltage recordings were made from 125
physiologically identified DRG neurons that met the acceptance
criteria defined in the methods. Only C-mechano-sensitive
nociceptors, Aβ-nociceptors and cutaneous Aβ-LTMs were
included in the present study. Other subtypes were either
not included (e.g., Aα/β-muscle spindle afferent neurons) or
not encountered including C-LTMs, C-cooling, Aδ-nociceptors
and Aδ-LTMs. Of the 125 neurons recorded, 67 neurons (20
C-nociceptors, 20 Aβ-nociceptors, and 27 cutaneous Aβ-LTMs)
were recorded from L4/L5 DRGs in control rats, and 58
neurons (15 C-nociceptors, 13 Aβ-nociceptors, and 30 cutaneous
Aβ-LTMs) were recorded from STZ rats.
STZ Induces Spontaneous Firing in
Aβ-Nociceptors and Aβ-LTMs but Not
C-Mechanosensitive Nociceptors
None of control C-nociceptors (0/20), Aβ-nociceptors (0/20)
or cutaneous Aβ-LTMs (0/27) exhibited spontaneous activity
(SA). Of the STZ neurons, none of the C-nociceptors (0/15)
fired spontaneously, but 23% (7/30) and 15% (2/13) of
cutaneous Aβ-LTMs and Aβ-nociceptors showed SA, respectively
(Figure 2). Figure 2 also shows example records of three typical
Aβ-LTMs with SA. These neurons fired spontaneously at a rate
of 0.15 Hz (Figure 2A), 0.53 Hz (Figure 2B), and 0.59 Hz
(Figure 2C). As shown in Figure 2D the incidence of Aβ-LTMs,
but not Aβ-nociceptors with SA is significant (P < 0.05 Fisher
exact test). The median SA rate for the whole sample of Aβ-LTMs
was 0.59 Hz (Figure 2E).
Activation of Kv7 Channels With
Retigabine Suppressed STZ-Induced SA
in Aβ-LTMs
We have recently shown that retigabine given intraperitoneally
at a dose of 15mg/kg attenuated mechanical hypersensitivity in
STZ rats (Djouhri et al., 2019). Given that PNP is due partly
to SA in DRG neurons (see section “Introduction”), we sought
to determine whether activation of Kv7 channels with retigabine
modulates SA in Aβ-LTMs that we see in STZ-rats. Interestingly,
we found that intravenous administration of retigabine at a
dose of 6 mg/kg substantially reduced SA rate in all Aβ-LTMs
examined (n = 7) as illustrated for the three Aβ-LTMs shown in
Figures 2A–C. Indeed, 15 min after retigabine injection, the rate
of SA in the neuron shown in Figure 2A was reduced by ∼80%
(from 0.15 to 0.03 Hz), whereas in the other two neurons, the
SA rate was reduced by 58% (from 0.53 to 0.22, Figure 2B) and
91% (from 0.59 to 0.05 Hz Figure 2C). The median SA rate for
the whole sample of Aβ-LTMs tested was significantly (P < 0.01)
reduced by ∼85% (from 0.59 to 0.09 Hz) 15 min after retigabine
administration (Figure 2E). Only one of the two spontaneously
firing Aβ-nociceptors was examined for the effects of retigabine;
FIGURE 1 | Behavioral signs of mechanical and heat hypersensitivity in
STZ-diabetic rats. Data are presented as mean ± SEM. STZ treatment
significantly decreased the mean paw withdrawal threshold (PWT) (A) and the
mean paw withdrawal latency (PWL) (B) in STZ rats (n = 10) 5 weeks
post-STZ. The decrease in both PWT and PWL was highly significant
(P < 0.001) indicating that the STZ-treated rats developed mechanical and
heat hypersensitivity. Comparisons are between values before STZ treatment
(pre-STZ, open bars) and 5 weeks post-STZ (5W, black bars). Statistical tests
were made with paired t-test. The level of statistical significance is:
∗∗∗P < 0.001.
its SA rate was also reduced (by∼70%) 15 min after by retigabine





We compared resting membrane potential (Em) in STZ
Aβ-LTMs with those of control Aβ-LTMs because EM could
influence SA. As shown in Figure 2F, there was no significant
difference in the median Ems of Aβ-LTMs between STZ and
control rats. However, the Ems of Aβ-LTMs were significantly
hyperpolarized 15 min after retigabine administration (P< 0.001,
paired t-test). The median Em decreased from −51 to −71 mV
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FIGURE 2 | Effects of retigabine on spontaneous activity (SA) and membrane potential (Em) in Aβ-LTMs in STZ rats. Shown in panels (A–C) are example records of
three typical spontaneously active Aβ-LTMs recorded from STZ rats before and 15 min after systemic administration of retigabine (6 mg/kg, i.v.). The left traces (A,B
and C,B) are somatic APs evoked by dorsal root electrical stimulation and recorded intracellularly from these three Aβ-LTMs; the CV (m/s) of each neuron is given
above the Ems shown by dotted lines. The middle traces in panels (A–C) are original records of these neurons firing spontaneously at different rates before
retigabine administration (BRT). The traces on the right in panels (A–C) illustrate that 15 min after retigabine (ART), the SA rate of these neurons was reduced from
0.15 to 0.03 Hz, 0.53 to 0.22 Hz, and 0.59 to 0.05 Hz, respectively. Shown below the middle trace in panel (C) is part of the trace shown in panel (C) (in a box) on
an expanded time scale (note different time scales). Panel (D) shows that the percentage of Aβ-LTMs with SA (but not Aβ-nociceptors) is significantly greater (Fisher
exact test, P < 0.05) than that of control Aβ-LTMs. Panel (E) shows that the median SA rate (0.59 Hz) for the whole sample of Aβ-LTMs tested (n = 7) was
significantly (P < 0.01) reduced to 0.09 Hz 15 min after retigabine (ART) administration. Panel (F) shows that retigabine (6 mg/kg, i.v.) caused a highly significant
decrease (hyperpolarization) in the median resting membrane potential (Em) of the Aβ-LTMs in STZ rats (P < 0.001, paired t-test). Note that there was no significant
difference in the median Em between STZ and control Aβ-LTMs. The voltage and time scales to the right of AP shown in panel (B) are for all three evoked APs. The
dotted lines on the traces indicate AP overshoot. *P < 0.05; **P < 0.01.
(Figure 2F). Retigabine had no significant effects on other AP
variables in Aβ-LTMs (Supplementary Figure S1).
STZ Induces Decreased Electrical
Thresholds in Aβ-but Not C-Nociceptors
To avoid the risk of sensitizing and/or losing the recorded DRG
neurons, we did not measure their mechanical thresholds
(see section “Discussion”). However, we compared the
dorsal root electrical thresholds of control and STZ C-and
Aβ-nociceptors, and found that the median electrical threshold
of Aβ-nociceptors (Figure 4A) (but not C-nociceptors,
Figure 3A) was significantly (P < 0.05) lower than that of
control Aβ-nociceptors.
STZ Induces Other Changes in
Electrophysiological Properties of C-and
Aβ-Nociceptors and Aβ-LTMs
Several changes in electrophysiological variables were found
in both C-and Aβ-nociceptors in STZ-rats. These include
significant decreases in: (1) AP and rise time (RT) durations in
C-nociceptors (Figures 3F,G) and Aβ-nociceptors (Figures 4F,G)
and (2) AHP duration and amplitude in Aβ- nociceptors
(Figures 4H,I). The decreased AP duration in both C-and
Aβ-nociceptors was largely due to a significant decrease in the
duration of RT (Figures 3G, 4G) but not in fall time (data not
shown). There was no significant changes in the other variables
measured including CV, Em, AP fall time, AP amplitude, AP
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overshoot and electrical threshold exhibited in C-nociceptors
(Figure 3). However, there was a highly significant (P < 0.001)
decrease (by 80%) in the median electrical threshold in Aβfiber
nociceptors (Figure 4A). Furthermore, as shown in Figure 4
there was significant decreases in the CV, AP duration, RT
AHP duration and AHP amplitude in Aβ-nociceptors. We also
examined whether the aforementioned variables also change in
subtypes of cutaneous Aα/β-LTMs. The significant changes found
in cutaneous Aβ-LTMs (grouped together) were decreased CV,
AHP duration and AHP amplitude (Supplementary Figure S1).
The faster AP and AHP kinetics and decreased AHP amplitude
induced by STZ in A-fiber nociceptive and LTMs are likely to
cause repetitive firing in these neurons resulting in increased
afferent input to the CNS.
DISCUSSION
We report several novel electrophysiological changes in
Aβ-LTMs, and C-and Aβ-nociceptors in STZ-rats that are
likely to contribute to DPNP pathogenesis. These include:
(1) increased incidence of SA in Aβ-LTMs that may result
in dysesthesias/paresthesias associated with DPNP, and (2)
faster AP and AHP kinetics, and reduced electrical thresholds
(C-and/or Aβ-nociceptors) that may lead to their repetitive
firing and sensitization respectively, and thereby contribute to
development of DPNP. Furthermore, we found that activation of
Kv7 channels with retigabine suppressed STZ-induced SA, and
caused membrane hyperpolarization in Aβ-LTMs, suggesting
that the reduction in SA rate was a direct consequence of the
hyperpolarizing effects of retigabine.
We used the STZ model, a well-established model of DPNP,
that has been shown by numerous studies to exhibit long
lasting behavioral signs of DPNP including mechanical and
heat hypersensitivity (see Djouhri et al., 2019 and references
therein). Consistent with those studies and with our recent
study (Djouhri et al., 2019) we found that STZ-diabetic rats
developed mechanical and heat hypersensitivity 5 weeks post-
STZ. However, unlike other models of PNP such as those
induced by traumatic nerve injury or chemotherapy that exhibit
spontaneous/ongoing pain behavior and cold hypersensitivity
(Djouhri et al., 2006, 2012; Al-Mazidi et al., 2018), we found that
STZ-diabetic rats do not show these behaviors, in agreement with
our recent study (Djouhri et al., 2019). It is noteworthy, however,
that STZ model validity as a model of DPNP was challenged by
a number of investigators (Romanovsky et al., 2004; Cunha et al.,
2009; Bishnoi et al., 2011).
One of the interesting and novel findings of the present
study is that Aβ-LTMs, but not C-mechanosensitive nociceptors,
exibited signficant SA in STZ rats. Serra and his co-workers (Serra
et al., 2012) also found, using microneurographic recordings
from patients with diabetic neuropathy and STZ rats, significant
SA in C-mechanoinsensitive, but not C-mechanosensitive
nociceptors, but they did not record from afferent A-fibers. Other
studies that investigated the impact of diabetes on excitability of
primary afferent neurons/fibers have been inconsistent. Indeed,
some studies reported that SA occurs almost exclusively in
FIGURE 3 | Changes in AP variables in C-fiber mechano-sensitive
nociceptors in STZ rats. The graphs (A–I) show scatterplots of variables
measured 5 weeks post-STZ. These variables are: electrical threshold (A), CV
(B), Em (C), AP height (D), AP overshoot (E), AP duration at base (F), Rise
time (RT) (G), AHP duration (AHP 80%, H) and AHP amplitude (I). Each dot in
these graphs and in those shown in Figure 4 represents a value from one
neuron. Medians are superimposed. Note the significant decreases in the
durations of AP (F) and RT (G), but not in other variables. Comparisons
between medians in columns 1 (control, blue dots) and column 2 (STZ, red
dots) were with the Mann–Whitney U test. The level of statistical significance is
as follows: ∗P < 0.05; ∗∗P < 0.01.
C-fibers in diabetic BB/Wistar rats (Burchiel et al., 1985), while
other studies found no SA in this subtype of afferent fibers
in STZ rats (Ahlgren et al., 1992; Chen and Levine, 2001).
A significant increase in incidence of C-fibers with SA but not
in Aδ-or Aβ-afferents was also reported by another study (Khan
et al., 2002). However, these co-workers found that all CV groups
in STZ-rats exhibited a significant increase in SA frequency
and lower activation thresholds and augmented responses to
mechanical stimuli. In contrast, another study (Chen and Levine,
2001) found no significant change in mechanical thresholds
in STZ-diabetic rats. The causes for the apparent discrepancy
between these various studies are not clear, but might be due to
differences in the nerve type used for recordings, rat strains, time
interval post-STZ and/or different recording methodologies.
Another interesting finding of the present study is that
activation of Kv7 channels with retigabine caused membrane
hyperpolarization and profound suppression of SA in Aβ-LTMs.
These findings suggest that retigabine exerts its anti-allodynic
effects in STZ rats (Djouhri et al., 2019) by causing membrane
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FIGURE 4 | Changes in AP variables in Aβ-nociceptors in STZ rats. The
variables shown are the same as those shown in Figure 3. Note the
significant decreases in the CV (B), durations of AP (F), RT (G), and AHP (H)
and in AHP amplitude (I). Details are as in Figure 2. Note that there was no
significant change in the other variables: electrical threshold (A), resting
membrane potential (C), AP height (D), AP overshoot (E) and
afterhyperpolarization duration to 80% recovery (H).
hyperpolarization in this subpopulation of DRG neurons.
Retigabine has also been shown to induce membrane
hyperpolarization in several neuronal types, including DRG
(Passmore et al., 2003) and spinal cord (Rivera-Arconada
and Lopez-Garcia, 2005) neurons, as well as axotomized
afferent neurons in mice (Roza and Lopez-Garcia, 2008). The
hyperpolarizing effect of retiagbine is likely to be due to a
shift in the K+ channel opening to more negative potentials
(Rundfeldt and Netzer, 2000; Tatulian et al., 2001; Schwarz
et al., 2006; Vervaeke et al., 2006). Although previous studies
have implicated Aβ-afferent neurons (Xu et al., 2015), but
not capsaicin-sensitive C-nociceptors (Khan et al., 2002) in
STZ-induced mechanical hypersensitivity in mice, our current
findings extend those findings and show that the functional
identity of those Aβ-afferent neurons, at least in the rat, is
Aβ-LTMs and probably not Aβ-nociceptors.
Retigabine has also been shown to block or reduce: (1)
SA induced by saphenous nerve injury in almost all C-fibers
and two putative Aβ-LTMs tested (Bernal et al., 2016), (2)
SA in small dissociated DRG neurons following spinal cord
injury (Wu et al., 2017), and in axotomized sensory fibers
(Roza and Lopez-Garcia, 2008), (3) excitability of C- fibers
in humans suffering from polyneuropathy (Lang et al., 2008),
and (4) C- and Aδ-fiber discharges induced by heat stimuli
(see (Brown and Passmore, 2009)). It is known that retigabine
works by activating Kv7 channels mediating the low threshold
and non-inactivating outward K+ (M) current that results from
homo- or heteromeric assemblies of KCNQ proteins (Brown
and Adams, 1980; Jentsch, 2000). The exact site of retigabine
action remains to be determined, but it could be any of the
anatomical compartments of DRG neuron because: (a) Kv7
channels are expressed in the somata of DRG neurons, and in
their peripheral and central terminals (see (Du et al., 2018)), and
(b) retigabine effects have been described at the nodal membrane
of myelinated axons in peripheral nerve (Devaux et al., 2004;
Schwarz et al., 2006) as well as at the somata level and at
peripheral and central terminals of primary afferent neurons (see
(Brown and Passmore, 2009).
It is noteworthy that retigabine exhibits non-Kv7 channel
effects including positive allosteric modulation of GABA subtypes
as well as blockade of voltage-gated Ca2+ and Kv2.1 channels
(see Stas et al., 2016 and refrences therein). The Kv7 channel
inhibitor XE991 also has been shown to have off-target effect on
Na+ channels (Sun et al., 2019). Therefore, the possibility that
changes in neuronal excitability caused by these Kv7 channels
modulators are due to their non-Kv7 channel effects cannot be
excluded. To ensure that the observed effects of retigabine on SA
are mediated by Kv7 channels, ideally one should conduct further
experiments using a Kv7 inhibitor such as XE991 to show that the
effects of retigabine on SA in Aβ-LTMs are prevented by pre- or
co-treatment with a Kv7 channel blocker. However, since XE991
has been found to induce repetitive AP firing in rat lumbar DRG
neurons (Barkai et al., 2017), administration of XE991 before or
with retigabine is likely to induce SA in non-spontaneously firing
DRG neurons. This would make interpreting the findings of such
experiments very difficult. Nevertheless, further experiments are
required to determine whether the other electrophysiological
changes in Aβ-nociceptors and Aβ-LTMs including changes in
AP and AHP variables are mediated by KV7 channels. However,
the findings of such experiments should be interpreted with
caution because, as noted above, both retigabine and XE991,
the most widely used modulators of KV7 channels, have off-
target effects. Indeed, XE991 may not be an ideal compound to
evaluate the influence of blocking channels on nerve excitability,
as suggested previously (Sun et al., 2019).
Our current findings of changes in AP and AHP variables
in Aβ-nociceptors or Aβ-LTMs are in agreement with those
of a previous in vitro study (Kriz and Padjen, 2003) that also
reported other changes in Aβ-fibers from isolated sural nerves
in STZ-rats. These in vitro and in vivo preclinical findings are
consistent with the clinical findings of impaired perception of
vibration (see Garrow and Boulton, 2006) which is known to
be mediated by Aβ-fibers (e.g., Claus et al., 1993). Our results
of decreased CV in Aβ-nociceptors in STZ rats which is likely
to result for demyelination, are also in agreement with those
of other animal studies (e.g., Chen and Levine, 2001) and
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with clinical studies that showed slowing of CV in A-fibers
in patients with DN (Herrmann et al., 2002). In contract,
another clinical study reported a reduction in CV of C mechano-
sensitive fibers, but not C-mechano-insensitive fibers in patients
with DN (Orstavik et al., 2006). The findings that Aβ-LTMs
exhibit SA in STZ-rats may result in unpleasant sensations
(dysesthesias/paresthesias) experienced by many patients with
DPNP. Furthermore, SA in primary afferent neurons is believed
to trigger and/or maintain central sensitization (see e.g., Baron
et al., 2010), promoting hypersensitivity to normally innocuous
stimulus (allodynia). In the presence of central sensitization
during PNP conditions, nerve impulses carried centrally from
the periphery along Aβ-LTMs are believed to be amplified
and acquire access to the central nociceptive system, and
thereby contribute to mechanical hypersensitivity associated with
PNP. Normally central sensitization is driven by inputs from
C-nociceptors (see Latremoliere and Woolf, 2009; von Hehn
et al., 2012), but during chronic pain states, Aβ-LTMs are
thought to exhibit phenotypic changes that would render them
capable of triggering or maintaining central sensitization (Liu
et al., 2000). On the other hand, spontaneous firing in Aβ-LTMs
is expected, under normal conditions, to reduce transmission
of pain signals at the spinal cord level via the gate control
mechanism (Melzack and Wall, 1965). However, it is possible
that this inhibitory mechanism is overridden by facilitatory spinal
mechanisms involved in chronic pain conditions.
One of the major strengths of this study is that it is the
first in vivo study that investigated electrophysiological changes
in different subtypes of physiologically identified DRG neurons.
We believe this is important because, as noted above, subtypes
of DRG neuron are likely to contribute to different aspects of
DPNP. We also believe that it is important to investigate these
DRG neurons in vivo in their native environment that changes
during chronic pain states in a complex way that cannot be
readily mimicked in vitro (see Djouhri et al., 2018). Indeed,
loss in vitro of the chemical environment including target-
derived trophic factors such as NGF and BDNF, and dissociation-
induced damage of DRG neurons profoundly alters properties
of these neurons including their normal electrophysiological
values against which comparisons are made (Kerekes et al.,
2000). One limitation of the present study is that we did not
routinely measure the mechanical thresholds of neurons, but
precise determination of thresholds requires application of more
stimuli to tissues that increases the risk of losing the recording.
Another potential limitation of our study is the use of the general
anesthetic pentobarbital that my affect the excitability of DRG
neurons via modulating some ion channels. However, changes
in the excitability of DRG neurons that we see in STZ rats are
unlikely to be due to effects of pentobarbital because it was
used in both control and STZ rats and because pentobarbital has
been shown to have negligible effects on excitability of cutaneous
Aβ-mechanoreceptive afferents (Cheng et al., 2013).
In conclusions, we have shown, in an established rat model of
DPNP, that Aβ-LTMs, but not C-mechanosensitive nociceptors,
exhibit significant SA, and that activation of Kv7 channels
with systemic retigabine causes membrane hyperpolarization
and suppression of SA in this subpopulation of DRG neurons
in STZ-rats. These findings suggest that Kv7 channels are
involved in mechanisms of SA generation in Aβ-LTMs, and taken
together with our previous findings of significant attenuation
of mechanical hypersensitivity (allodynia) in STZ rats (Djouhri
et al., 2019) suggest that retigabine exerts its antiallodynic effects
probably by causing membrane hyperpolarization in Aβ-LTMs.
DATA AVAILABILITY STATEMENT
The datasets generated for this study are available on request to
the corresponding author.
ETHICS STATEMENT
The experimental protocols were approved by the University of
Liverpool Ethical review committee, and complied throughout
with the UK Animals (Scientific Procedures) Act 1986.
AUTHOR CONTRIBUTIONS
LD designed the research, conducted some of the
electrophysiological experiments, and wrote the first draft
of the manuscript. AZ helped in analyzing the behavioral data,
writing, editing, and revising the manuscript. TS helped in
conducting the behavioral and electrophysiological experiments,
writing, editing, and revising the manuscript. SA helped in
writing, editing, and revising the MS. All authors approved final
version of the manuscript.
FUNDING
This research work was supported by a Medical Research Council
grant (G0700420) and a Ph.D. studentship from Biotechnology
and Biological Sciences Research Council to LD.
ACKNOWLEDGMENTS
We thank staff at BSU of University of Liverpool for their
technical support and help.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found online
at: https://www.frontiersin.org/articles/10.3389/fnins.2020.
00530/full#supplementary-material
FIGURE S1 | Changes in AP variables in cutaneous Aβ-LTMs in STZ rats and the
effects of retigabine on those variables in Aβ-LTMS with SA. The variables shown
are the same as those shown in Figure 3. Note the significant decreases in the
CV (B) and AHP duration (H) and AHP amplitude (I). Note that administration of
retigabine (6 mg/kg, i.v.) had not significant effects on all the variables. Details are
as in Figure 3. Note that there was no significant changes in the other variables:
electrical threshold (A), AP height (C), AP overshoot (D), AP duration (E), AP rise
time (F), and AP fall time (G).
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